Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

ADAP Advocacy Releases Report on Patient Medical Debt





Findings from Quantitative Surveying of Patients in the United States

WASHINGTON, DC, April 23, 2025 /24-7PressRelease/ -- ADAP Advocacy today, as part of its 340B Project and in collaboration with the Community Access National Network (CANN), published a report on patient experiences with and perspectives on medical debt. The report – "Patient Medical Debt: Findings from Quantitative Surveying of Patients in the United States – April 2025" – found that nearly four out of five patients delayed or avoided medical care due to inability to pay (excluding the purchase of prescription drugs), and three-fourths of patients held medical debt.

Brandon M. Macsata, CEO of ADAP Advocacy, summarized: "The rising medical debt crisis in the United States is impacting patients across all chronic health conditions, including patients living with HIV. We are concerned that the big hospital systems are reaping the benefits of the 340B Drug Pricing Program, affording them lucrative drug rebates that are supposed to be used to expand access to affordable healthcare services, but not using those dollars as intended by the law. Studies have shown nearly seventy-five percent of medical debt is actually debt owed to hospitals, or hospital debt."

ADAP Advocacy received 673 responses to the Patient Medical Debt Survey. The report's key findings include:

• When asked if they have ever delayed or avoided medical care (excluding the purchase of prescription drugs) due to their inability to pay, 77% of respondents (n=484) indicated that indicated "yes."
• Similarly, 71% (n=442) indicated that they have delayed or avoided purchasing prescription drugs because of their inability to afford associated out-of-pocket costs.
• When asked if they personally held medical debt, 74% of respondents (n=460) indicated they did.
• Those respondents holding medical debt indicated that their debt is largely held by hospitals (39%) and specialty care physicians (22%).
• 66% (n=304) indicated that their medical debt is currently in collections.
• 40% (n=182) indicated that medical debt had impacted their credit scores.
• 70% (n=324) indicated that medical debt impacted their health status.

The report included findings from a quantitative survey of patients in the United States. The report can be downloaded here: https://tinyurl.com/yc635dcz.

To learn more about ADAP Advocacy, 340B Drug Pricing Program, or patient medical debt, please email info@adapadvocacy.org.

About ADAP Advocacy: ADAP Advocacy's mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improves access to care for persons living with HIV/AIDS. ADAP Advocacy works with advocates, community, health care, government, patients, pharmaceutical companies, and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.